These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 34749405

  • 41. Fetal liver length measurement at mid-pregnancy among fetuses at risk as a predictor of hemoglobin Bart's disease.
    Luewan S, Tongprasert F, Piyamongkol W, Wanapirak C, Tongsong T.
    J Perinatol; 2011 Mar; 31(3):157-60. PubMed ID: 20651692
    [Abstract] [Full Text] [Related]

  • 42. Analysis of fetal blood using capillary electrophoresis system: a simple method for prenatal diagnosis of severe thalassemia diseases.
    Srivorakun H, Fucharoen G, Sae-Ung N, Sanchaisuriya K, Ratanasiri T, Fucharoen S.
    Eur J Haematol; 2009 Jul; 83(1):57-65. PubMed ID: 19226360
    [Abstract] [Full Text] [Related]

  • 43. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks--experience with the first 59 cases.
    Lam YH, Tang MH.
    Prenat Diagn; 2000 Nov; 20(11):900-4. PubMed ID: 11113892
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Splenic circumference at midpregnancy as a predictor of hemoglobin Bart's disease among fetuses at risk.
    Srisupundit K, Tongprasert F, Luewan S, Sirichotiyakul S, Tongsong T.
    Gynecol Obstet Invest; 2011 Nov; 72(1):63-7. PubMed ID: 21389673
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Prenatal ultrasound evaluation of fetal Hb Bart's disease among pregnancies at risk at 11 to 14 weeks of gestation.
    Sirichotiyakul S, Luewan S, Srisupundit K, Tongprasert F, Tongsong T.
    Prenat Diagn; 2014 Mar; 34(3):230-4. PubMed ID: 24318930
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
    Tongsong T, Wanapirak C, Sirichotiyakul S.
    Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
    [Abstract] [Full Text] [Related]

  • 50. Amniotic fluid metabolomic and lipidomic alterations associated with hemoglobin Bart's diseases.
    Chen X, Chen H, Nie H, Li G, Su J, Cao X, Cao Y, Wei F.
    Metabolomics; 2021 Sep 06; 17(9):82. PubMed ID: 34490587
    [Abstract] [Full Text] [Related]

  • 51. A Fetus with Hb Bart's Disease Due to Maternal Uniparental Disomy for Chromosome 16.
    Au PK, Kan AS, Tang MH, Leung KY, Chan KY, Tang TW, Lau ET.
    Hemoglobin; 2016 Sep 06; 40(1):66-9. PubMed ID: 26574185
    [Abstract] [Full Text] [Related]

  • 52. Prenatal control of Hb Bart's hydrops fetalis: a two-year experience at a mainland Chinese hospital.
    Liao C, Pan M, Han J, Yang X, Zhen L, Li J, Li R, Li DZ.
    J Matern Fetal Neonatal Med; 2015 Mar 06; 28(4):413-5. PubMed ID: 24766075
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Prenatal diagnosis of Hb Bart's hydrops fetalis by PCR technique: Pramongkutklao experience.
    Torcharus K, Sriphaisal T, Krutvecho T, Ketupanya A, Vuthiwong C, Suwanasophon C, Noonai A.
    Southeast Asian J Trop Med Public Health; 1995 Mar 06; 26 Suppl 1():287-90. PubMed ID: 8629126
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Prenatal ultrasound monitoring of homozygous α0-thalassemia-induced fetal anemia.
    Lee HH, Mak AS, Poon CF, Leung KY.
    Best Pract Res Clin Obstet Gynaecol; 2017 Feb 06; 39():53-62. PubMed ID: 27863915
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.